Global Liquid Biopsy Market | Industry, Trends, Analysis 2018-2026

1
Global Liquid Biopsy Market Forecast 2018-2026
2
Agenda
Regional Insights
Key Findings
Market Insights
Competitive Insights
3
Key Findings
Left Image Slide

• Developments in precision medicines, increasing
  prevalence of cancer cases in the elderly
  population and supportive government initiatives
  are factors that are contributing to the
  expansion of the Liquid Biopsy market.
• Over the forecast period of 2018-2026, the global
  liquid biopsy market is expected to rise at a
  CAGR of 22.97.

Many desktop publishing packages and web page
editors now use Lorem Ipsum as their default
model text, and a search for 'lorem ipsum' will
uncover many web sites still in their infancy.
Various versions have evolved.
4
Market Insights

• The Global Liquid Biopsy market is segmented into
  Biomarker types, Indication, Analysis Platform,
  Products, Analysis purpose, and End users.
• The biomarker types include nucleic acids,
  proteins, extracellular vesicles and cells.
• The Indication segment of the market can further
  be classified cancer indications, NIPT, and
  Transplant. The analysis platform of this market
  includes Microarray, NGS, Proteomics, PCR, and
  other analysis platform.
• The products for this market can be further
  classified into exosomes, CTCS and CTDNA
  products.
• The Analysis purpose for this market is for
  Therapy guidance, early detection/screening,
  monitoring and diagnosis.
• The end-users for this market are Hospitals,
  Physicians office laboratories, and Clinical
  diagnostic laboratories.

5
Image Slide
Lorem Ipsum
Lorem Ipsum
Lorem Ipsum
Lorem Ipsum
Lorem Ipsum
Lorem Ipsum has been the industry's standard
dummy text ever since the 1500s, when an unknown
printer took a galley of type and scrambled it to
make a type specimen book.
Lorem Ipsum has been the industry's standard
dummy text ever since the 1500s, when an unknown
printer took a galley of type and scrambled it to
make a type specimen book.
Lorem Ipsum has been the industry's standard
dummy text ever since the 1500s, when an unknown
printer took a galley of type and scrambled it to
make a type specimen book.
Lorem Ipsum has been the industry's standard
dummy text ever since the 1500s, when an unknown
printer took a galley of type and scrambled it to
make a type specimen book.
Lorem Ipsum has been the industry's standard
dummy text ever since the 1500s, when an unknown
printer took a galley of type and scrambled it to
make a type specimen book.
6
The Global Liquid Biopsy Market is expected to
rise at a CAGR of 22.97, over the forecast
period of 2018-2026.
Request Free Sample
7
Request Free Sample

• The North America Display Market is expected to
  grow at CAGR of 3.19 throughout the estimated
  years 2019-2027.

8
Request Free Sample

• The Europe Display Market is mostly centered on
  the freemium model that is the key driver for
  market growth at 5.94 CAGR during the
  forecasting period of 2019-2027.

9

• The Asia Pacific Display Market is expected to
  reach from xx billion in 2018 to xx billion by
  2027, growing at a compound annual growth rate of
  9.90 over the estimated period.

Request Free Sample
10
Competitive Insights

• Some of the leading market players in the global
  liquid biopsy market are Agilent Technologies
  Inc, Ad-Tech Medical Instrument Corp, Argon
  Medical Devices Inc, Becton, B. Braun Melsungen
  Ag, Dickinson, Bio-Rad Laboratories Inc, Boston
  Scientific Corporation, C. R. Bard, Inc, Cook
  Group Inc, Cintec Medical Ltd, Fischer Medical
  Technologies Llc, Planmeca Oy, I.M.S.
  Internazionale Medico Scientifica Srl,Roche
  Diagnostics Ltd, and Qiagen N.V.

11
(No Transcript)
12
(No Transcript)
13
(No Transcript)